WATERTOWN, Mass.–(BUSINESS WIRE)–#AIEnabled—Konovo, a technology-first healthcare intelligence company, appointed real-world data (RWD) veteran Gadi Lachman to its Board of Directors. Lachman brings over 20 years of leadership in health technologies and a proven track record in developing scalable research platforms that will help accelerate Konovo’s initiatives to transform the life science market insights sector.
Lachman was most recently the founder and CEO of TriNetX, a global health research network that connects healthcare organizations, biopharma companies, and contract research organizations to advance clinical research. As the founder of TriNetX, he led the development of a global health research network that leverages real-world data from hundreds of hospitals to advance clinical research and drug development. Under his leadership, TriNetX evolved into a market-leading platform used by thousands of researchers worldwide. Prior to TriNetX, Lachman held senior leadership roles at several healthcare technology companies, including TriZetto, American Well, and Eliza Corporation.
Lachman’s appointment aligns with Konovo’s tech-first approach to connecting fragmented insights across the life sciences research ecosystem. His experience with healthcare technology and global research platforms will support the expansion of Konovo’s AI-native intelligent platform.
“Gadi is an innovator and builder with deep expertise in increasing access to real-world data across the healthcare industry,» said Tal Rosenberg, CEO of Konovo. «He shares our passion for connecting fragmented data to develop insights, and his guidance and perspective will be instrumental to thoughtfully expanding Konovo’s platform and product suite.»
As a member of the Board of Directors, Lachman will help accelerate Konovo’s technological innovation. “Gadi is an experienced leader in healthcare data,” said Christina Reszka, Partner at Frazier Healthcare Partners. “We are fortunate to have the benefit of his strategic thinking and unique insights.”
Lachman is the newest member of the Konovo Board of Directors since the Company launched its new brand and evolved mission in April 2025.
“Joining the board at such a pivotal time in Konovo’s evolution is tremendously exciting,” said Gadi Lachman. “Konovo has an incredible foundation of innovation and industry leadership and is creating the future of connected market research to overcome today’s barriers to insights. As I’ve learned in my career, access to the right data at the right time can change everything.”
About Konovo
Konovo is a global healthcare company on a mission to transform research through technology. Konovo simplifies the research process, connects fragmented insights, and enhances access to hard-to-reach healthcare professionals.
Konovo supports leading market research agencies, consultancies, and pharmaceutical and healthcare brands, by connecting them to specialized healthcare audiences— physicians, KOLs, patients, caregivers, payers, and allied healthcare professionals—via an intelligent platform.
Konovo builds on a long history of success in research through the merger of InCrowd, Survey Healthcare Global (SHG), and GlocalMind. Operating across the Americas, Europe, and Asia, Konovo connects the industry to an extensive network of audiences, partners, and data, enabling deeper, more actionable insights across healthcare.
Konovo is a portfolio company of Frazier Healthcare Partners. To learn more, visit www.konovo.com.
Contacts
Mary Kae Marinac
PR Representative for Konovo
[email protected]
978-685-3136
